It’s a sobering statistic: 1 in 8 women in the United States will be diagnosed with breast cancer during her lifetime.1 ...

As cancer treatment costs have increased, identifying and treating early-stage cancer sooner reduces expenses and improves ...

Breast cancer is the second leading cause of cancer death in women. Early detection results in 99% five-year survival rates.

The increase in breast cancer rates among younger patients is occurring as the incidence of other early-onset cancers — ...

Women with high-risk HER2-positive breast cancer lived significantly longer with adjuvant trastuzumab emtansine (T-DM1, ...

Danielle Fishel is sharing an update about her health, saying she has completed “active cancer treatment” following her ...

Patients with HER-2 positive early breast cancer with residual invasive disease after neoadjuvant therapy were randomly ...

Vanessa Rissetto overcame incredible odds to secure millions in funding for Culina Health, a company transforming access to ...

Patient outcomes appeared to be more heavily driven by breast cancer stage than delays in diagnosis, researchers found.

Dr. Maxwell Lloyd shared the importance of improving patient access to innovative therapies like Orserdu at the 2024 San Antonio Breast Cancer Symposium.

The Tomosynthesis Mammographic Imaging Screening Trial (TMIST) has reached its enrollment goal of 108,508 women, as announced ...

A new report from the American Cancer Society shows that cancer mortality rates continue to decline, but diagnoses are on the ...